KALA BIO, Inc. Quarterly Operating Income (Loss) in USD from Q2 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
KALA BIO, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2016 to Q3 2024.
  • KALA BIO, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$9.99M, a 14% decline year-over-year.
  • KALA BIO, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$41.1M, a 2.1% decline year-over-year.
  • KALA BIO, Inc. annual Operating Income (Loss) for 2023 was -$39.7M, a 51.5% increase from 2022.
  • KALA BIO, Inc. annual Operating Income (Loss) for 2022 was -$81.7M, a 37.3% increase from 2021.
  • KALA BIO, Inc. annual Operating Income (Loss) for 2021 was -$130M, a 35.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$41.1M -$9.99M -$1.23M -14% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$39.9M -$9.61M -$6K -0.06% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$39.9M -$11.9M -$248K -2.12% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$39.7M -$9.62M +$632K +6.17% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$40.3M -$8.76M +$5.81M +39.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$46.1M -$9.6M +$16.4M +63% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$62.5M -$11.7M +$19.2M +62.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$81.7M -$10.3M +$36.6M +78.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$118M -$14.6M +$11.5M +44.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$130M -$26M +$3.07M +10.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$133M -$30.9M -$2.6M -9.18% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$130M -$46.8M -$17.8M -61.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-03
Q3 2021 -$112M -$26.1M -$229K -0.89% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$112M -$29M -$7.77M -36.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$104M -$28.3M -$8.19M -40.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$96.2M -$29M -$8.79M -43.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$87.4M -$25.8M -$4.28M -19.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$83.2M -$21.3M +$1.13M +5.04% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$84.3M -$20.1M +$3.93M +16.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$88.2M -$20.2M +$3.37M +14.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$91.6M -$21.6M -$6.07M -39.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$85.5M -$22.4M -$7.89M -54.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$77.6M -$24.1M -$12.9M -116% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$64.7M -$23.6M -$12.4M -112% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-12
Q3 2018 -$52.3M -$15.5M -$5.96M -62.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$46.3M -$14.5M -$4.89M -50.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$41.4M -$11.1M -$1.57M -16.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$39.9M -$11.1M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$9.53M +$213K +2.19% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$9.63M +$20K +0.21% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$9.57M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q3 2016 -$9.75M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$9.65M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.